Results 1 to 10 of about 643,213 (261)

Evaluating the effectiveness of mass drug administration on lymphatic filariasis transmission and assessment of post-mass drug administration surveillance in Nigeria’s Federal Capital Territory [PDF]

open access: yesInfectious Diseases of Poverty
Background Nigeria’s Federal Capital Territory (FCT) launched annual mass drug administration (MDA) in its four lymphatic filariasis (LF)-endemic councils in 2011, achieving sustained high coverage and pre-transmission assessment survey success.
Juliana Ajuma Amanyi-Enegela   +12 more
doaj   +2 more sources

Evaluation of Triple Drug Administration for Lymphatic Filariasis in Prayagraj District, Uttar Pradesh, India: A Cross-sectional Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
Introduction: Unplanned urbanisation and improper sanitary system in many cities in a developing country increase cases of vector borne diseases. Among these, filariasis is a major health problem in India.
Khurshid Parveen, Lal Divakar Singh
doaj   +1 more source

Community perceptions and acceptability of mass drug administration for the control of neglected tropical diseases in Asia-Pacific countries: A systematic scoping review of qualitative research

open access: yesPLoS Neglected Tropical Diseases, 2022
Background Preventative chemotherapy and mass drug administration have been identified as effective strategies for the prevention, treatment, control and elimination of several NTDs in the Asia-Pacific region.
Elke Mitchell   +8 more
doaj   +3 more sources

Mass drug administration for endemic scabies: a systematic review

open access: yesTropical Diseases, Travel Medicine and Vaccines, 2021
Background Scabies is an extremely fastidious infestation caused by the Sarcoptes scabiei mite. It causes a persistent itch that can disrupt a person’s mental health, sleep, and overall quality of life.
Giulia Rinaldi, Kholoud Porter
doaj   +1 more source

National mass drug administration costs for lymphatic filariasis elimination. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2007
BACKGROUND: Because lymphatic filariasis (LF) elimination efforts are hampered by a dearth of economic information about the cost of mass drug administration (MDA) programs (using either albendazole with diethylcarbamazine [DEC] or albendazole with ...
Ann S Goldman   +21 more
doaj   +1 more source

Antimalarial mass drug administration in large populations and the evolution of drug resistance.

open access: yesPLOS Global Public Health, 2023
Mass drug administration (MDA) with antimalarials has been shown to reduce prevalence and interrupt transmission in small populations, in populations with reliable access to antimalarial drugs, and in populations where sustained improvements in diagnosis
Tran Dang Nguyen   +5 more
doaj   +1 more source

Costs of mass drug administration for scabies in Fiji.

open access: yesPLoS Neglected Tropical Diseases, 2022
In 2019, the Murdoch Children's Research Institute in partnership with the Fiji Ministry of Health and Medical Services carried out an integrated mass drug administration (MDA) for the treatment of scabies and lymphatic filariasis in the Northern ...
Maria Mow   +14 more
doaj   +1 more source

The Impact of Mass Drug Administration on Lymphatic Filariasis

open access: yesJournal of Tropical Medicine, 2022
Mass drug administration (MDA) has made a significant impact on the control of lymphatic filariasis (LF) since the establishment of the Global Programme to Eliminate Lymphatic Filariasis. However, its implementation is associated with several challenges,
Isaac Frimpong Aboagye   +1 more
doaj   +1 more source

FILARIASIS DISTRIBUTION AND COVERAGE OF MASS DRUG ADMINISTRATION

open access: yesJurnal Berkala Epidemiologi, 2019
Background: Filariasis is still a serious health problem in Indonesia. One of the endemic areas is Demak, which implemented a mass drug administration (MDA) elimination programme in 2016. However, filariasis was still found in 2017–18.
Ikha Solikha, M. Sakundarno Adi
doaj   +1 more source

Mass Drug Administration: Contextual Factor Considerations. [PDF]

open access: hybridAm J Trop Med Hyg
Schneider ZD   +6 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy